Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice

Oncogene

Volumn 18, Issue 37, 1999, Pages 5159-5166

  Yao, Yao ^a   Slosberg, Eric D ^a   Wang, Lei ^a   Hibshoosh, Hanina ^a   Zhang, Yu Jing ^b   Xing, Wang Qiu ^a   Santella, Regina M ^a,b   Weinstein, I Bernard ^a,b  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cdc25B; DMBA; Mammary tumor; MMTV LTR; Synergy; Transgenic mice

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; CYCLIN DEPENDENT KINASE; PHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOGENESIS; BREAST EPITHELIUM; CANCER SUSCEPTIBILITY; CARCINOGENICITY; CHEMICAL CARCINOGENESIS; CONTROLLED STUDY; FEMALE; MALE; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CDC25 PHOSPHATASE; CELL CYCLE PROTEINS; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; GENETIC PREDISPOSITION TO DISEASE; ISOENZYMES; MAMMARY NEOPLASMS, EXPERIMENTAL; MAMMARY TUMOR VIRUS, MOUSE; MICE; MICE, INBRED CBA; MICE, TRANSGENIC; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT FUSION PROTEINS; TERMINAL REPEAT SEQUENCES; TRANSGENES;

ANIMALIA; MAMMARY TUMOR ONCOVIRUS; MOUSE MAMMARY TUMOR VIRUS; MUS MUSCULUS; ONCOVIRINAE;

EID: 0033575959     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202908     Document Type: Article

References (65)

1. Aldaz CM, Liao QY. LaBate M and Johnston DA, (1996). Carcinogenesis, 17, 2069-2072.
2. Amundadottir L. Johnson M, Merlino G, Smith G and Dickson R. (1995). Cell Growth Differ., 6, 737-748.
3. Archuleta M, Born J, Montano R and Burchiel S. (1992). Toxicol. Appl. Pharmacol., 113, 133-137.
4. Baldin V. Cans C, Knibichler M and Ducommun B. (1997a). J. Biol. Chem., 272, 32731-32734.
5. Baldin V. Cans C, Superti-Furga G and Ducommun B. (1997b). Oncogene, 14, 2485-2495.
6. Beato M. (1991). FASEB J., 5, 2044-2051.
7. Bortner DM and Rosenberg MP. (1995). Cell Growth Differ., 6, 1579-1589.
8. Bortner DM and Rosenberg MP. (1997). Mol. Cell. Biol., 17, 453-459.
9. Bruggemeier U, Kalff M, Franke S, Scheidereit C, Beato M. (1991). Cell, 64, 565-572.
10. Cardiff RD and Muller WJ. (1993). Transgenic mouse models of mammary tumorigenesis. In: Cancer Surveys: The Molecular Pathology of Cancer. Imperial Cancer Research Fund, Vol. 16, pp. 97-113.
11. Clarke PR, Hoffmann I, Draetta G and Karsenti E. (1993). Mol. Cell. Biol., 4, 397-411.
12. Dandekar S, Sukumar S, Zarbl H, Young L and Cardiff RD. (1986). Mol. Cell. Biol., 6, 4104-4108.
13. Draetta G and Eckstein J. (1997). Biochim. Biophys. Acta., 1332, M53-M63.
14. Furnari B, Rhind N and Russell P. (1997). Science, 277, 1495-1497.
15. Gabrielli BG, Clark JM, McCormack AK and Ellem KA. (1997). J. Biol. Chem., 272, 28607-28614.
16. Gabrielli BG, DeSouza C, Tonks I, Clark J, Hayward N and Ellem K. 11996). J. Cell. Sci., 109, 1081-1093.
17. Galaktionov K, Chen X and Beach D. (1996). Nature, 382, 511-517.
18. Galaktionov K, Jessus C and Beach D. (1995a). Genes Dev., 9, 1046-1058.
19. Galaktionov K, Lee AK, Eckstein J, Draetta G, Meckler J, Loda M and Beach D. (1995b). Science, 269, 1575-1577.
20. Gasparotto D, Maestro R, Piccinin S, Vukosavljevic T, Barzan L, Sulfaro S and Boiocchi M. (1997). Cancer Res., 57, 2366-2368.
21. Grieco D, Avvedimento EV and Gottesman ME. (1994). Proc. Natl. Acad. Sci. USA, 91, 9896-9900.
22. Guy CT, Cardiff RD and Muller WJ. (1992). Mol. Cell. Biol., 12, 954-961.
23. Halter SA, Dempsey P, Matsui Y, Stokes M, Graves-Deal R, Hogan B and Coffey R. (1992). Am. J. Path., 140, 1131-1146.
24. Hartwell LH and Weinert TA. (1989). Science, 246, 629-634.
25. Hennighausen L, Wall RJ, Tillmann U, Li M and Furth P. (1995). J. Cell. Biochem., 59, 463-472.
26. Henrard D and Ross SR. (1988). J. Virol., 62, 3046-3049.
27. Hoffmann I, Draetta G and Karsenti E. (1994). EMBO J., 13, 4302-4310.
28. Hoffmann I and Karsenti E. (1994). J. Cell. Sci. Suppl., 18, 75-79.
29. Hogan B, Beddington R, Costantini F and Lacy E. (1994). Manipulating the Mouse Embryo: A Laboratory Manual. CSHL Press.
30. Iavarone A and Massague J. (1997). Nature, 387, 417-422.
31. Jiang W, Kahn SM, Zhou P, Zhang YJ, Cacaoe AM, Infante AS, Doi S, Santella RM and Weinstein IB. (1993). Oncogene, 8, 3447-3457.
32. Jinno S, Suto K, Nagata A, Igarashi M, Kanaoka Y, Nojima H and Okayama H. (1994). EMBO J., 13, 1549-1556.
33. Klein MG, Yao Y, Slosberg ED, Lima CD, Doki Y and Weinstein IB. (1998). Exp. Cell Res., 244, 26-32.
34. Kudo Y, Yasui W, Ue T, Yamamoto S, Yokozaki H, Nikai H and Tahara E. (1997). Jpn. J. Cancer Res., 88, 947-952.
35. Kumagai A and Dunphy WG. (1996). Science, 273, 1377-1380.
36. Li B, Kittrell FS, Median D and Rosen JM. (1995). Mol. Carcinog., 14, 75-83.
37. Matsui Y, Halter SA, Holt JT, Hogan BL and Coffey RJ. (1990). Cell, 61, 1147-1155.
38. Mayford M, Bach ME, Huang YY, Wang L, Hawkins RD, Kandel ER. (1996). Science, 274, 1678-1683.
39. Medina D, Butel JS, Sochcr SH and Miller FL. (1980). Cancer Res., 40, 368-373.
40. Millar JB, McGowan CH, Lenaers G, Jones R and Russell P. (1991). EMBO J., 10, 4301-4309.
41. Morgan DO. (1995). Nature, 374, 131-134.
42. Muller W, Sinn E, Pattengale P, Wallace R and Leder P. (1988). Cell, 54, 105-115.
43. Nagata A, Igarashi M, Jinno S, Suto K and Okayama H. (1991). New Biol., 3, 959-968.
44. Nielson LL, Discafani CM, Gurnani M and Tyler RD. (1991). Cancer Res., 51, 3762-3767.
45. Ogg S, Gabrielli B and Piwnica-Worms H. (1994). J. Biol. Chem., 269, 30461-30469.
46. Peng C, Graves P, Thoma P, Wu Z, Shaw A and Piwnica-Worms H. (1997). Science, 277, 1501-1505.
47. Peng C-Y, Graves PR, Ogg S, Thoma RS, Byrnes MJ, Wu Z, Stephenson MT and Piwnica-Worms H. (1998). Cell Growth Differ., 9, 197-208.
48. Pierce DF, Gorska AE, Chytil A, Meise KS, Page DE, Coffey RJ and Moses HL. (1995). Proc. Natl Acad. Sci. USA, 92, 4254-4258.
49. Quezado MM, Middleton LP, Bryant B, Lane K, Weiss SW, Merino MJ. (1998). Hum. Pathol., 29, 604-608.
50. Rollini P, Billotte J, Kolb E and Diggelmann H. (1992). J. Virol., 66, 4580-4586.
51. Ross SR, Hsu CL, Cboi Y, Mok E and Dudley JP. (1990). Mol. Cell. Biol., 10, 5822-5829.
52. Russell P and Nurse P. (1986). Cell, 45, 145-153.
53. Sadhu K, Reed SI, Richardson H and Russell P. (1990). Proc. Natl. Acad. Sci. USA, 87, 5139-5143.
54. Sanchez Y, Wong C, Thoma RS, Richman R, Wu Z, Piwnica-Worms H and Elledge SJ. (1997). Science, 277, 1497-1501.
55. Santarelli R, Tzeng YJ, Zimmermann C, Guhl E, Graessmann A. (1996). Oncogene, 12, 496-505.
56. Sherr CJ. (1993). Cell, 73, 1059-1065.
57. Spitkovsky D, Jansen-Durr P, Karsenti E and Hoffman I. (1996). Oncogene, 2549-2554.
58. Stewart TA, Pattengale PK and Leder P. (1984). Cell, 38, 627-637.
59. Stutman O. (1975). Adv. Cancer Res., 22, 261-422.
60. Truss M, Chalepakis G, Pina B, Barettino D, Bruggemeier U, Kalff M, Slater EP, Beato M. (1992). J. Steroid Biochem. Mol. Biol., 41, 241-248.
61. Turusov VS. (1994). Tumors of the mouse. Pathology of turnouts in laboratory animals. 2, 776, International Agency for Research on Cancer, Lyon.
62. Wang TC, Cardiff RD, Zukerberg L, Lees E, Arnold A and Schmidt EV. (1994). Nature, 369, 669-671.
63. Weinberg RA. (1989). Cancer Res., 49, 3713-3721.
64. Witty JP, Lempka T, Coffey RJ and Matrisian LM. (1995). Cancer Res., 55, 1401-1406.
65. Wu W, Fan YH, Kemp BL, Walsh G, Mao L. (1998). Proc. Am. Assoc. Cancer Res., 39, 544.